Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Eisai Shares Outstanding 2006-2019 | ESALY

Eisai shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Eisai shares outstanding for the quarter ending December 31, 2019 were M, a 100% decline year-over-year.
  • Eisai 2020 shares outstanding were 0.287B, a 0.01% decline from 2019.
  • Eisai 2019 shares outstanding were 0.287B, a 0.18% increase from 2018.
  • Eisai 2018 shares outstanding were 0.286B, a 0.1% decline from 2017.
  
Eisai Annual Shares Outstanding
(Millions of Shares)
2020 287
2019 287
2018 286
2017 286
2016 286
2015 286
2014 285
2013 285
2012 285
2011 285
2010 285
2009 285
2008 284
2007 285
2006 286
2005 287
Eisai Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31
2019-06-30 286
2018-06-30 286
2017-06-30 286
2016-06-30 286
2015-06-30 286
2015-03-31 286
2014-12-31 285
2014-09-30 285
2014-06-30 285
2014-03-31 285
2013-12-31 285
2013-09-30 285
2013-06-30 285
2013-03-31 285
2012-12-31 285
2012-09-30 286
2012-06-30 285
2012-03-31 284
2011-12-31 285
2011-09-30 284
2011-06-30 285
2011-03-31 280
2010-12-31 285
2010-09-30 285
2010-06-30 285
2010-03-31 285
2009-12-31 285
2009-09-30 285
2009-06-30
2009-03-31 285
2008-12-31 285
2008-09-30 285
2008-06-30 285
2008-03-31 284
2007-12-31 285
2007-09-30 284
2007-06-30 284
2007-03-31 284
2006-12-31 285
2006-09-30 285
2006-06-30 286
2006-03-31 286
2005-12-31 286
2005-09-30 286
2005-06-30 286
2005-03-31 286
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $24.541B $6.400B
Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.927B 37.42
Takeda Pharmaceutical (TAK) Japan $55.110B 9.66
Astellas Pharma (ALPMY) Japan $29.863B 15.13
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.852B 20.79
Grifols, S.A (GRFS) Spain $12.782B 15.89
Neurocrine Biosciences (NBIX) United States $12.083B 55.84
Catalent (CTLT) United States $11.806B 45.64
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.486B 45.12
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.952B 9.53
United Therapeutics (UTHR) United States $5.184B 9.82
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.605B 502.78
Nektar Therapeutics (NKTR) United States $4.412B 0.00
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.857B 11.73
ChemoCentryx (CCXI) United States $3.816B 0.00
PTC Therapeutics (PTCT) United States $3.737B 0.00
FibroGen (FGEN) United States $3.734B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.518B 10.35
Pacira BioSciences (PCRX) United States $2.382B 48.74
Sage Therapeutics (SAGE) United States $2.305B 0.00
Cronos Group (CRON) Canada $2.159B 61.90
Corcept Therapeutics (CORT) United States $1.930B 19.14
Xencor (XNCR) United States $1.878B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.759B 0.00
USANA Health Sciences (USNA) United States $1.737B 17.81
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.604B 19.91
Ironwood Pharmaceuticals (IRWD) United States $1.592B 12.18
Zogenix (ZGNX) United States $1.565B 0.00
Esperion Therapeutics (ESPR) United States $1.456B 0.00
Karyopharm Therapeutics (KPTI) United States $1.424B 0.00
Heron Therapeutics (HRTX) United States $1.399B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.350B 14.55
Theravance Biopharma (TBPH) Cayman Islands $1.335B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.107B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.007B 44.93
BioCryst Pharmaceuticals (BCRX) United States $0.958B 0.00
Tilray (TLRY) Canada $0.946B 0.00
ImmunoGen (IMGN) United States $0.814B 0.00
Endo (ENDP) Ireland $0.783B 1.21
Molecular Templates (MTEM) United States $0.633B 0.00
Ardelyx (ARDX) United States $0.627B 0.00
Aerie Pharmaceuticals (AERI) United States $0.623B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
VAXART, INC (VXRT) United States $0.605B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.539B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.525B 12.70
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 18.92
Flexion Therapeutics (FLXN) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.455B 0.00
DURECT (DRRX) United States $0.433B 0.00
TherapeuticsMD (TXMD) United States $0.429B 0.00
Harpoon Therapeutics (HARP) United States $0.417B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.395B 0.00
Organogenesis Holdings (ORGO) United States $0.376B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
MEI Pharma (MEIP) United States $0.361B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.285B 0.00
Altimmune (ALT) United States $0.264B 0.00
Lannett Co Inc (LCI) United States $0.258B 5.65
Oasmia Pharmaceutical AB (OASMY) Sweden $0.257B 0.00
Redhill Biopharma (RDHL) Israel $0.246B 0.00
CASI Pharmaceuticals (CASI) United States $0.242B 0.00
Taiwan Liposome (TLC) Taiwan $0.234B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.17
KalVista Pharmaceuticals (KALV) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.202B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.183B 0.00
Nivalis Therapeutics (ALPN) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.95
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.146B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.142B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
CTI BioPharma (CTIC) United States $0.105B 0.00
Recro Pharma (REPH) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
MediWound (MDWD) Israel $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.097B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Sundial Growers (SNDL) Canada $0.084B 0.00
Biomerica (BMRA) United States $0.082B 0.00
Heat Biologics (HTBX) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
Lipocine (LPCN) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
CV Sciences (CVSI) United States $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.82
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.76
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.64
GTx (ONCT) United States $0.040B 0.00
Novan (NOVN) United States $0.039B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Shineco (TYHT) China $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00